NSE ScannerHospitals & Diagnostics · Medical/Nursing Services · NSE: THYROCARE · data 2026-10-30
Thyrocare Technologies Ltd
In plain words
Price: 31.1% below its 52-week high of ₹662.
Delivery: 48.5% of traded shares were kept for delivery over the last 10 sessions, against 53.7% over the last 60.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹876 cr |
| Net profit (last 12 months) | ₹176 cr |
| Sales growth, 3 years (yearly) | 16.3% |
| Profit growth, 3 years (yearly) | 36.2% |
Smart-money activity
33/100 · Neutral over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 12/30: Delivery 47.1% over the last 20 sessions vs 51.2% in the 40 before (0.92x); shares delivered per day 1.24x usual; 2 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 9/15: 0 insider buy days (promoter group among them) and 2 SAST acquisition days in 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 7/15: 5 schemes hold it, about ₹492 cr in all (as of 2026-09-30). Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Insider ● Dividend ● Bonus
- 21 Sept 26Insider SAST disclosure: API Holdings Ltd acquired 8,12,00,000 shares +3.9% next session
- 17 Aug 26Insider SAST disclosure: Docon Technologies Private Limited +3 acquired 9,99,69,427 shares -2.5% next session
- 23 Jun 26Dividend Dividend ₹7 (ex-date) +2.0% next session
- 28 Nov 25Bonus Bonus 2:1 (ex-date)
- 24 Oct 25Dividend Dividend ₹7 (ex-date) +3.0% next session
- 25 Jul 25Dividend Dividend ₹21 (ex-date) -6.8% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Shareholding trend
| Holder | Sept 2026 | Mar 2026 | Mar 2025 |
|---|---|---|---|
| Promoters | 51.02% | 60.92% | 71.06% |
| Foreign institutions (FII) | 9.37% | 5.37% | 2.41% |
| Domestic institutions (DII) | 25.92% | 20.99% | 14.97% |
| Mutual funds | 22.91% | 19.45% | 12.97% |
| Retail investors | 8.97% | 8.54% | 7.57% |
| Number of shareholders | 75,186 | 73,377 | 57,403 |
Common questions
How much do promoters hold in Thyrocare Technologies Ltd?
Promoters held 51.02% of Thyrocare Technologies Ltd at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Thyrocare Technologies Ltd debt-free?
Its latest reported debt-to-equity ratio is 0.09, which is very low.
What is Thyrocare Technologies Ltd's P/E ratio?
About 41.5, based on the last 12 months' earnings and a price of ₹456.3 (data 2026-10-30).
What is the 52-week high and low of Thyrocare Technologies Ltd?
The 52-week high is ₹662 and the 52-week low is ₹342.55.
Mutual funds holding Thyrocare Technologies Ltd
From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 5 schemes holding about ₹492 cr; funds that hold it outside their top holdings may not be listed.
| Scheme | Fund house | % of fund | Value |
|---|---|---|---|
| ADITYA BIRLA SUN LIFE ELSS TAX SAVER FUND | Aditya Birla Sun Life Mutual Fund | 1.58% | ₹214 cr |
| NIPPON INDIA PHARMA FUND | Nippon India Mutual Fund | 2.24% | ₹205 cr |
| ADITYA BIRLA SUN LIFE BUSINESS CYCLE FUND | Aditya Birla Sun Life Mutual Fund | 2.18% | ₹38 cr |
| ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND | Aditya Birla Sun Life Mutual Fund | 1.76% | ₹19 cr |
| An open ended fund for investment for children having a lock-in for at least 5 years or till the child attains age of majority | Aditya Birla Sun Life Mutual Fund | 1.34% | ₹16 cr |
Similar companies
Dr. Agarwal's Health Care Ltd. (AGARWALEYE) · Vijaya Diagnostic Centre Ltd. (VIJAYA) · Metropolis Healthcare Ltd. (METROPOLIS) · Nephrocare Health Services Limited (NEPHROPLUS) · Jeena Sikho Lifecare Limited (JSLL)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open THYROCARE in NSE Scanner →